Hospitalization risks in the treatment of bipolar disorder: comparison of antipsychotic medications
- 1 May 2007
- journal article
- research article
- Published by Wiley in Bipolar Disorders
- Vol. 9 (3), 252-261
- https://doi.org/10.1111/j.1399-5618.2007.00394.x
Abstract
This study compared the relative risk for hospitalization of patients with bipolar and manic disorders receiving atypical and typical antipsychotics. This retrospective study was based on administrative claims data extracted from the PharMetrics database during 1999 through 2003. Comparisons were made among atypical antipsychotics (risperidone, olanzapine, quetiapine or ziprasidone), as well as between each of these versus a combined group of the leading typical antipsychotics. Relative risk for hospitalization was estimated with Cox proportional regression, which adjusted for differences in patient characteristics. Risperidone and olanzapine demonstrated higher risks for hospitalization than quetiapine [hazard ratio (HR) 1.19, p < 0.05 for both], translating into higher annual mental health inpatient charges of $260 per patient. Risperidone and olanzapine also showed higher estimated risks than ziprasidone, which approached the p < 0.05 threshold. Differences between each of the atypicals and the combined typicals were not significant. Patients with putative rapid cycling had a threefold greater risk for hospitalization than other patients with bipolar disorder. In these patients, comparisons among atypical antipsychotics showed that risperidone had a significantly higher hospitalization risk than olanzapine (HR 3.31, p < 0.05), resulting in higher annual mental health inpatient charges of $4,930 per patient. In the treatment of bipolar and manic disorders, risperidone and olanzapine were associated with a higher risk for hospitalization than quetiapine, and possibly ziprasidone. In the treatment of putative rapid cyclers, olanzapine was associated with a lower risk for hospitalization than risperidone.Keywords
This publication has 36 references indexed in Scilit:
- Is it asthma or COPD?Postgraduate Medicine, 2005
- Partial Compliance and Risk of Rehospitalization Among California Medicaid Patients With SchizophreniaPsychiatric Services, 2004
- The many forms of bipolar disorder: a modern look at an old illnessJournal of Affective Disorders, 2004
- Unipolar Mania Over the Course of a 20-Year Follow-Up StudyAmerican Journal of Psychiatry, 2003
- Extending indications for long-term pharmacotherapy: opportunities and challenges.American Journal of Psychiatry, 2002
- Atypical Antipsychotics in Bipolar and Schizoaffective DisordersPharmacopsychiatry, 2001
- Rehospitalization Rates of Chronically Ill Schizophrenic Patients Discharged on a Regimen of Risperidone, Olanzapine, or Conventional AntipsychoticsAmerican Journal of Psychiatry, 2001
- Effectiveness of Antipsychotic Therapy in a Naturalistic SettingPublished by Physicians Postgraduate Press, Inc ,1999
- Factors influencing relapse in the long-term course of schizophreniaSchizophrenia Research, 1997
- Lithium Prophylaxis in Recurrent Affective IllnessThe British Journal of Psychiatry, 1994